Grace Therapeutics, Inc. Nontrade Receivables, Current
Grace Therapeutics, Inc. (GRCE) had Nontrade Receivables, Current of $20.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:NontradeReceivablesCurrent · last filed 2026-08-13
- 2026-06-30: Nontrade Receivables, Current $20.00K.
- 2026-03-31: Nontrade Receivables, Current $20.00K.
- 2025-12-31: Nontrade Receivables, Current $20.00K.
- 2025-09-30: Nontrade Receivables, Current $20.00K.
| Period end | Nontrade Receivables, Current |
|---|---|
| 2026-06-30 | $20.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $20.00K 10-Q · filed 2026-08-13 |
| 2025-12-31 | $20.00K 10-Q · filed 2026-02-12 |
| 2025-09-30 | $20.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $20.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $126.00K 10-K · filed 2026-06-18 |
| 2024-12-31 | $301.00K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $415.00K 10-Q · filed 2024-11-13 |
| 2024-03-31 | $722.00K 10-K · filed 2025-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |